Ontology highlight
ABSTRACT: Background and aims
Tuberculous (TB) pericarditis (TBP), a TB of the heart, is linked to significant morbidity and mortality rates. Administering glucocorticoid therapy to individuals with TBP might enhance overall results and lower the likelihood of fatality. However, the actual clinical effectiveness of supplementary glucocorticoids remains uncertain. This study specifically evaluated the effects of prednisolone, prednisolone-antiretroviral therapy (ART) interaction, and other potential risk factors in reducing the hazard of the composite outcome, death, cardiac tamponade, and constriction, among TBP and human immunodeficiency virus (HIV) patients.Methods
The data used in this study were obtained from the investigation of the Management of Pericarditis trial, a multicentr
SUBMITTER: Iddrisu AK
PROVIDER: S-EPMC10867395 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature